PMID: 8948295Nov 1, 1996Paper

Natural remission in inflammatory polyarthritis: issues of definition and prediction

British Journal of Rheumatology
B HarrisonA J Silman

Abstract

This paper reports the frequency and predictors of remission (no arthritis on examination and no treatment with second-line drugs or steroids within the previous 3 months) in 358 patients with early inflammatory polyarthritis (IP) referred to the Norfolk Arthritis Register. Two years after referral, 91 patients (25%) were in remission, 32 of whom had also been in remission at 1 yr. Remission rates were twice as high in patients with undifferentiated inflammatory polyarthritis at baseline as in those who satisfied criteria for rheumatoid arthritis. To identify predictors of remission, a logistic regression model was developed on a random two-thirds of the patients and validated on the remaining one-third. Remission at 2 yr was associated with male gender and fewer than six tender joints at baseline. However, even the best-fitting model was not sensitive enough to be useful clinically. Thus, amongst patients with early IP in the community, remission rates at 2 yr are low. Further, it was impossible, using simple clinical measures, to predict those patients whose arthritis would resolve.

Citations

Aug 14, 2003·Best Practice & Research. Clinical Rheumatology·Deborah P M Symmons
Aug 2, 2001·Internal Medicine Journal·A A Williamson, G J McColl
Aug 6, 2011·International Journal of Rheumatic Diseases·Chingching FoocharoenAjanee Mahakkanukrauh
Jun 8, 2013·Annals of the Rheumatic Diseases·K V C Wevers-de BoerC F Allaart
Feb 14, 2004·Annals of the Rheumatic Diseases·J S Smolen, D Aletaha
Jun 9, 2005·Annals of the Rheumatic Diseases·H MäkinenT Sokka
Dec 16, 1998·Annals of the Rheumatic Diseases·L B van de PutteP L van Riel
Oct 3, 2002·Annual Review of Medicine·Raphaela Goldbach-Mansky, Peter E Lipsky
Aug 2, 2006·Arthritis Research & Therapy·Annette H M van der Helm-van MilTom W J Huizinga
Oct 17, 2009·Arthritis Research & Therapy·Mohamed M ThabetAnnette H M van der Helm-van Mil
Sep 12, 2003·Current Rheumatology Reports·Josef S Smolen, Daniel Aletaha
Nov 1, 2011·Autoimmunity Reviews·Ignazio OlivieriRoberto Caporali
Apr 1, 2009·Reumatología clinica·Francisco Javier Narváez García
Nov 17, 2005·Rheumatic Diseases Clinics of North America·Mark A Quinn, Sally Cox
Nov 17, 2005·Rheumatic Diseases Clinics of North America·Carol A HitchonHani S El-Gabalawy
Sep 2, 2008·Arthritis and Rheumatism·Tuulikki SokkaUNKNOWN Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group
Sep 19, 2006·Best Practice & Research. Clinical Rheumatology·Kathryn Dao, John J Cush
Sep 19, 2006·Best Practice & Research. Clinical Rheumatology·Karim RazaChristopher D Buckley
Feb 8, 2006·Seminars in Arthritis and Rheumatism·Dinesh KhannaCatherine H MacLean
May 19, 2001·Best Practice & Research. Clinical Rheumatology·W E OllierD Symmons
Feb 24, 2009·Best Practice & Research. Clinical Rheumatology·Karim Raza, Andrew Filer
Apr 17, 2013·Revista brasileira de reumatologia·Carlos Frederico Arend
Feb 13, 2002·Arthritis and Rheumatism·Henk VisserJohanna M W Hazes
Jan 20, 2004·Arthritis and Rheumatism·Esmeralda T H MolenaarBen A C Dijkmans
Oct 5, 2017·Therapeutic Advances in Musculoskeletal Disease·Sofia Ajeganova, Tom Huizinga
Nov 10, 2017·Nature Reviews. Rheumatology·Hanna W van SteenbergenAnnette H M van der Helm-van Mil

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.